Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12215160 | Treatment of patients having c-met exon 14 skipping mutations | Roland Knoblauch, Sheri Moores | 2025-02-04 |
| 11879013 | Combination therapies with bispecific anti-EGFR/c-Met antibodies and third generation EGFR tyrosine kinase inhibitors | Matthew Lorenzi, Sheri Moores | 2024-01-23 |
| 11827708 | Proteins comprising HLA-G antigen binding domains and their uses | Natasa Obermajer, Adam Zwolak, Dirk Brehmer, Desiree De Lange, Julien Häsler +6 more | 2023-11-28 |
| 11472830 | Cyclic dinucleotides as sting agonists | Gilles Bignan, Peter J. Connolly, James P. Edwards, Stuart Emanuel, Tianbao Lu +5 more | 2022-10-18 |
| 10869869 | Method of adjuvant cancer treatment | Peter F. Lebowitz | 2020-12-22 |
| 9402846 | Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancer | Melissa Dumble, Tona Gilmer, Rakesh Kumar, Peter F. Lebowitz, Shannon Renae Morris | 2016-08-02 |
| 9067873 | Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses | Yijun Deng, Theodore J. Nitz, Thomas R. Bailey, Yanming Zhang | 2015-06-30 |
| 8962667 | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | Theodore J. Nitz, Janet A. Gaboury, Christopher J. Burns, Daniel C. Pevear, Thomas A. Lessen +1 more | 2015-02-24 |
| 8952018 | Pharmaceutical combination of MEK inhibitor and B-Raf inhibitors | Melissa Dumble, Rakesh Kumar, Peter F. Lebowitz | 2015-02-10 |
| 8835450 | Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer | Melissa Dumble, Tona Gilmer, Rakesh Kumar, Peter F. Lebowitz, Shannon Renae Morris | 2014-09-16 |
| 8796298 | Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancer | Melissa Dumble, Tona Gilmer, Rakesh Kumar, Peter F. Lebowitz, Shannon Renae Morris | 2014-08-05 |
| 8703781 | Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors | Melissa Dumble, Rakesh Kumar, Peter F. Lebowitz | 2014-04-22 |
| 8642596 | Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses | Yijun Deng, Theodore J. Nitz, Thomas R. Bailey, Yuanming Zhang | 2014-02-04 |
| 7556955 | Nucleic acids encoding Candida kefyr cytosine deaminase | Yuqiao Shen, Amy M. Delaney, Charles A. Omer | 2009-07-07 |
| 7414113 | Antibody that specifically binds to Candida kefyr Cytosine deaminase | Yuqiao Shen, Amy M. Delaney, Charles A. Omer | 2008-08-19 |
| 7396679 | Oncolytic adenovirus | Leisa Johnson, Ali Fattaey, Terry Hermiston, Yuqiao Shen | 2008-07-08 |
| 7141404 | Candida kefyr cytosine deaminase | Yuqiao Shen, Amy M. Delaney, Charles A. Omer | 2006-11-28 |
| 7078030 | Oncolytic adenovirus | Leisa Johnson, Ali Fattaey, Terry Hermiston, Jerry Shen | 2006-07-18 |
| 6723316 | Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth | Terry Hermiston | 2004-04-20 |
| 6660259 | Herpes simplex virus for treating unwanted hyperproliferative cell growth | Terry Hermiston | 2003-12-09 |